By
Tricitynews
Chandigarh
03rd August:- If
the homework is not done, the taste of the recipe will be never be tasty; Take
wise decisions in your initial years of your academics; something try
differently with your heart and soul to find out your own ways of success in
your life. Develop your personality as disciplined person, timely commitment
breaks any barriers these were the remarkable words of Dr. Sanjit Singh Lamba;
the Managing Director of Eisai Pharmaceuticals India Pvt. Ltd., Visakhapatnam,;
who was the chief guest of today at NIPER’s
Inauguration of Academic Session 2018-19. In short, a thought provoking & an eye opener
lecture was delivered by Dr. Lamba to the newly joined Masters & PhDs
students of NIPER, S.A.S. Nagar.
The event
was organized at NIPER’s convention centre with a warm welcome of the dignitaries
and lamp lighting followed by “Saraswati Vandana”. A welcome note delivered by The Director
NIPER, Prof. NIPER Director, Prof. Raghuram Rao Akkinepally. In his welcome
address, he briefed the audience about NIPER
background and the achievements of the NIPER students & staff. He explained
that the curriculum is interdisciplinary and the students are exposed to
sophisticated instruments required in the pharmaceutical industry. He informed
that our aim is also to act as a nucleus of academia-industry interaction, and
for that, we have a number of service centers which cater to the needs of the
pharma industry. It is my belief that academic institutes and teachers, in
particular, have a crucial role to play in bridging the gap between the trained
manpower that academic institutes generate and the demands of the pharma
sector. I believe that NIPER S.A.S. Nagar will be able to fulfill this promise.
Dean, NIPER, Prof. P.V. Bharatam introduced the Chief Guest to the
audience. He briefed about the academia and industrial profile of Dr. Sanjit
Singh Lamba.
Dr. Sanjit Singh Lamba delivered the lecture on “Indian Pharmaceutical
Industry, Changing times. “The agenda of the lecture includes Snapshot of India Pharmaceutical Industry, Road of Opportunities, Challenges, an overview of Eisai India were discussed. He stated that India Indian Pharma
Market is a leading Pharma producer and one of the highest exports among
fastest growing industries of the world. There is a rapid growth in healthcare
sector. India has contributed not just to the health outcomes in India but also
globally. 60%+ of global vaccine production, 30%+ Annual UNICEF supply globally
are some of them. We continue to drive availability of high quality drugs at low costs. Under
the Position
in Infrastructure & Capabilities Production costs for commodity generics
continue to be low in India—the country ranks lowest in conversion costs, 50%
lower than the US or UK and other developed countries. India has strong
capabilities in generics R&D. However, many instances of quality issues related to products
manufactured in India have surfaced. Drug
quality is one of the major challenges been faced by the industry & has
been reported extensively in the public domain. Under the “Make in India”. He informed about the philosophy of the Eisai
Group’s corporate to give first thought to patients and their families and to
increasing the benefits health care provides. At the end of his lecture he
advised students to establish yourself, remain flexible/adjustable and do not
be rigid specially .He congratulated all the NIPER students to get the
opportunity to work in globally recognized the best Academia institution The NIPER
S.A.S. Nagar, that has set a bench mark to the pharmaceutical education.
The Director NIPER honored the chief guest with a memento.
No comments:
Post a Comment